期刊文献+

来氟米特离体透皮吸收的研究 被引量:1

Study on the permeability of leflunomide in vitro
下载PDF
导出
摘要 目的 :研究来氟米特的透皮特性和脂质体对此的影响。方法 :采用改良 Franz扩散池 ,以离体皮肤为渗透屏障 ,渗透系数为指标 ,HPL C法测定来氟米特浓度。结果 :来氟米特本身具有较好的皮肤渗透性能 ,脂质体对来氟米特的皮肤渗透性能影响不大。 结论 :来氟米特可以采用经皮肤局部给药的方式给药。 Objective: To study the permeability of leflunomide and the effect of liposome on its permeability. Methods: Modified Franz diffusion cell adopted as apparatus for in vitro skin permeation. Various excised skins were used as permeation barriers and permeation coefficient was used as index. The concentration of leflunomide in the samples was measured by HPLC. Results: Leflunomide had a good permeability, but the effect of liposome on permeability was not very strong. Conclusion: It is feasible that leflunomide is applied through skin. [
出处 《第二军医大学学报》 CAS CSCD 北大核心 2000年第10期971-974,共4页 Academic Journal of Second Military Medical University
基金 全军"九五"医学科研规划基金资助项目!(98M0 77)
关键词 来氟米特 脂质体 透皮吸收 leflunomide liposome percutaneous absorption
  • 相关文献

参考文献3

二级参考文献4

  • 1阎家麒,赵敏,王九一.SOD脂质体生产新工艺研究[J].中国生化药物杂志,1994,15(2):79-81. 被引量:9
  • 25.Touitou E,Junginger HE,Weiner ND,et al.Liposomes as carriers for topical and transdermal delivery[J].J Pharm Sci,1994,83(9)∶1189
  • 3刘志强,浙江医科大学学报,1986年,15卷,3期,100页
  • 4姚志建.超氧化物歧化酶的脂质体载体[J]军事医学科学院院刊,1984(03).

共引文献27

同被引文献15

  • 1余邦良,马亚平,刘全忠,苏照英,白威,周宗贞,杨柳.铂类抗癌药物研究进展[J].海南大学学报(自然科学版),2005,23(1):72-80. 被引量:16
  • 2TSUKASAKI N, WHITWORTH CA, RYBAK LP. Acute changes in cochlear potentials due to cisplatin [J]. Hear Res, 2000,149 (1-2):189.
  • 3MEECH RP, CAMPBELL KC, HUGHES LP, et al. A semiquantitalive analysis of the effects of cisplatin on the rat stria vascularis[J]. Hear Res,1998, 124(1-2):44.
  • 4MA KISEL, LN KULIK, IS TSYBOVSKY, et al. Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat [J].2001,1(216): 105-114.
  • 5T NOMURA, K YASUDA, T YAMADA, et al.Gene expression and anfitumor effects following direct interferon (IFN)-g gene transfer with naked plasmid DNA and I)C-chol liposome complexes in mice[J]. Gene Therapy, 1999, 6:121-129.
  • 6GEORGIA KOROMILA, GEORGE PA, MICHANETZIS, et al. Heparin incorporating liposomes as a delivery system of heparin from PET-covered metallic stents: Effect on haemecompatibility[J]. Biomaterials, 2006,27(12) :2525-2533.
  • 7GEORGOULIAS V, ARDAVANIS A , AGELIDOU A, et al. Docetaxel Versus Docetaxel Plus Cisplatin as Front2line Treatment of Patients with Advanced Non-small Lung Cancer: a Randomized, Muhicenter Phase Ⅲ Trial[J]. J Clin Oncol, 2004, 22(13):2602-2609.
  • 8KIM YH, KIM JS, CHOI YH, et al. Phase Ⅱ Study of Docetaxel and Cisplatin Combination Chemotherapy in Metastatic or Unresectable Localized Non Small Cell Lung Cancer[J]. Int J Clin Oncot, 2002,7(2) :114-119.
  • 9唐帆,毕津莲.普鲁卡因柔性脂质体的制备及载药研究[J].中国医学工程,2007,15(9):715-716. 被引量:5
  • 10黄水仙,谢民强,李仲汉,张宏征,龙镇.改性载顺铂磁性纳米药物靶向治疗鼻咽癌的实验研究[J].中国现代医学杂志,2007,17(24):2974-2978. 被引量:5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部